Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

RTTNews | 509 days ago
Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

(RTTNews) - Astellas Pharma Inc. announced Friday the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI (enzalutamide) as monotherapy or in combination with androgen deprivation therapy for the treatment of adult men with high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiotherapy.

The positive CHMP opinion is based on the results from the Phase 3 EMBARK trial.

The positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines in all 27 European Union (EU) member states as well as Iceland, Liechtenstein and Norway.

Astellas is also discussing the EMBARK data with other regulatory authorities to support additional license applications for XTANDI in this indication in 2024 and beyond.

read more
Bay Street Likely To Open On Positive Note

Bay Street Likely To Open On Positive Note

Canadian stocks may open higher on Wednesday, amid continued optimism about Fed interest rate cut, and easing geopolitical tensions ahead of talks between U.S. President Donald Trump and Russian President Vladimir Putin that is scheduled to take place on Friday.
RTTNews | 2h 1min ago
U.S. Dollar Extends Fall Amid Fed Rate Cut Speculation

U.S. Dollar Extends Fall Amid Fed Rate Cut Speculation

The U.S. dollar continued to trade lower against other major currencies in the European session on Wednesday, as the U.S. Consumer Price Index data from July has raised expectations that the Fed would lower interest rates in September.
RTTNews | 2h 26min ago
CAC 40 Up Nearly 0.5%; Essilor Rises Sharply

CAC 40 Up Nearly 0.5%; Essilor Rises Sharply

French stocks are gaining some ground in positive territory on Wednesday, extending previous session's rise, amid continued optimism the Fed will reduce interest rate next month, and on slightly easing concerns about tariff after the U.S. decided to extend its pause on higher tariffs against China till November 10.
RTTNews | 3h 38min ago
DAX Notably Higher As Fed Rate Cut Hopes, Easing Trade Tensions Lift Sentiment

DAX Notably Higher As Fed Rate Cut Hopes, Easing Trade Tensions Lift Sentiment

The German market is up firmly in positive territory on Wednesday, with stocks from several sectors posting solid gains, amid expectations of a rate cut by the Federal Reserve next month, and on hopes that the impact of tariffs on growth will be less severe than feared earlier. Investors are also digesting the nation's inflation data.
RTTNews | 4h 4min ago
Sensex, Nifty End Higher After Inflation Relief

Sensex, Nifty End Higher After Inflation Relief

Indian shares eked out modest gains on Wednesday after official data showed India's consumer price inflation eased more-than-expected in July to the lowest level in just over eight years, bringing inflation below RBI's tolerance band and raising prospects of another interest rate cut.
RTTNews | 4h 8min ago